⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for oat cell lung cancer

Every month we try and update this database with for oat cell lung cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of AZD2811 + Durvalumab in ES-SCLCNCT04745689
Small-Cell Lung...
Durvalumab
AZD2811
Carboplatin
Cisplatin
Etoposide
18 Years - 130 YearsAstraZeneca
Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)NCT03043872
Small Cell Lung...
Durvalumab
Tremelimumab
Carboplatin
Cisplatin
Etoposide
18 Years - 130 YearsAstraZeneca
Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)NCT03043872
Small Cell Lung...
Durvalumab
Tremelimumab
Carboplatin
Cisplatin
Etoposide
18 Years - 130 YearsAstraZeneca
Study of AZD2811 + Durvalumab in ES-SCLCNCT04745689
Small-Cell Lung...
Durvalumab
AZD2811
Carboplatin
Cisplatin
Etoposide
18 Years - 130 YearsAstraZeneca
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: